Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 466

1.

The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism.

Eichinger S, Weltermann A, Mannhalter C, Minar E, Bialonczyk C, Hirschl M, Schönauer V, Lechner K, Kyrle PA.

Arch Intern Med. 2002 Nov 11;162(20):2357-60.

PMID:
12418950
3.

FV Leiden mutation and risk of recurrent venous thromboembolism in Serbian population.

Kovac M, Mikovic D, Antonijevic N, Rakicevic L, Djordjevic V, Radojkovic D, Elezovic I.

J Thromb Thrombolysis. 2008 Jun;25(3):284-7. Epub 2007 Jun 5.

PMID:
17549437
4.

The risk of recurrent venous thromboembolism in patients with and without factor V Leiden.

Eichinger S, Pabinger I, Stümpflen A, Hirschl M, Bialonczyk C, Schneider B, Mannhalter C, Minar E, Lechner K, Kyrle PA.

Thromb Haemost. 1997 Apr;77(4):624-8.

PMID:
9134632
5.

Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study.

Simioni P, Tormene D, Prandoni P, Zerbinati P, Gavasso S, Cefalo P, Girolami A.

Blood. 2002 Mar 15;99(6):1938-42.

7.

Probability of recurrence of thrombosis in patients with and without factor V Leiden.

Rintelen C, Pabinger I, Knöbl P, Lechner K, Mannhalter C.

Thromb Haemost. 1996 Feb;75(2):229-32.

PMID:
8815565
8.

The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.

De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G.

N Engl J Med. 1999 Sep 9;341(11):801-6.

9.

The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders.

Meinardi JR, Middeldorp S, de Kam PJ, Koopman MM, van Pampus EC, Hamulyák K, Prins MH, Büller HR, van der Meer J.

Br J Haematol. 2002 Mar;116(3):625-31.

PMID:
11849222
10.

Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.

Lijfering WM, Middeldorp S, Veeger NJ, Hamulyák K, Prins MH, Büller HR, van der Meer J.

Circulation. 2010 Apr 20;121(15):1706-12. doi: 10.1161/CIRCULATIONAHA.109.906347. Epub 2010 Apr 5.

11.

The incidence of venous thromboembolism among Factor V Leiden carriers: a community-based cohort study.

Heit JA, Sobell JL, Li H, Sommer SS.

J Thromb Haemost. 2005 Feb;3(2):305-11.

12.

Testing for factor V Leiden in patients with pulmonary or venous thromboembolism: a cost-effectiveness analysis.

Eckman MH, Singh SK, Erban JK, Kao G.

Med Decis Making. 2002 Mar-Apr;22(2):108-24.

PMID:
11958494
13.

Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism.

Margaglione M, D'Andrea G, Colaizzo D, Cappucci G, del Popolo A, Brancaccio V, Ciampa A, Grandone E, Di Minno G.

Thromb Haemost. 1999 Dec;82(6):1583-7.

PMID:
10613638
14.

Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.

Ruggeri M, Gisslinger H, Tosetto A, Rintelen C, Mannhalter C, Pabinger I, Heis N, Castaman G, Missiaglia E, Lechner K, Rodeghiero F.

Am J Hematol. 2002 Sep;71(1):1-6.

15.

The risk of first venous thromboembolism during pregnancy and puerperium in double heterozygotes for factor V Leiden and prothrombin G20210A.

Martinelli I, Battaglioli T, De Stefano V, Tormene D, Valdrè L, Grandone E, Tosetto A, Mannucci PM; GIT (Gruppo Italiano Trombofilia).

J Thromb Haemost. 2008 Mar;6(3):494-8. doi: 10.1111/j.1538-7836.2007.02880.x. Epub 2007 Dec 19.

16.

Prothrombin A19911G polymorphism and the risk of venous thromboembolism.

Martinelli I, Battaglioli T, Tosetto A, Legnani C, Sottile L, Ghiotto R, Mannucci PM.

J Thromb Haemost. 2006 Dec;4(12):2582-6. Epub 2006 Sep 15.

17.

A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism.

Middeldorp S, Meinardi JR, Koopman MM, van Pampus EC, Hamulyák K, van Der Meer J, Prins MH, Büller HR.

Ann Intern Med. 2001 Sep 4;135(5):322-7.

PMID:
11529695
18.

Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis.

Meinardi JR, Middeldorp S, de Kam PJ, Koopman MM, van Pampus EC, Hamulyák K, Prins MH, Büller HR, van der Meer J.

Blood Coagul Fibrinolysis. 2001 Dec;12(8):713-20.

PMID:
11734673
19.

Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism.

Eichinger S, Weltermann A, Minar E, Stain M, Schönauer V, Schneider B, Kyrle PA.

Arch Intern Med. 2004 Jan 12;164(1):92-6.

PMID:
14718328
20.

The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation.

De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Rossi E, Chiusolo P, Casorelli I, Leone G.

Br J Haematol. 2001 Jun;113(3):630-5.

PMID:
11380448
Items per page

Supplemental Content

Write to the Help Desk